280 related articles for article (PubMed ID: 28386263)
1. Adaptive Immunity Is the Key to the Understanding of Autoimmune and Paraneoplastic Inflammatory Central Nervous System Disorders.
Weissert R
Front Immunol; 2017; 8():336. PubMed ID: 28386263
[TBL] [Abstract][Full Text] [Related]
2. [MHC tetramers: tracking specific immunity].
Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
[TBL] [Abstract][Full Text] [Related]
3. Neuronal injury in chronic CNS inflammation.
Zindler E; Zipp F
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
[TBL] [Abstract][Full Text] [Related]
4. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
[TBL] [Abstract][Full Text] [Related]
5. Spinal cord atrophy in neuromyelitis optica spectrum disorders.
Wang Y; Wang Y; Tan S; Lu Z
Mult Scler Relat Disord; 2016 Jul; 8():9-10. PubMed ID: 27456868
[TBL] [Abstract][Full Text] [Related]
6. Lesions of the posterior limb of the internal capsule in neuromyelitis optica spectrum disorder.
Long Y; Wu L; Zhong R; Ouyang X; Liang J; Gao C; Chen X; Qiu W; Chang Y; Wang Z; Ye J
Neurol Res; 2017 May; 39(5):448-452. PubMed ID: 28262035
[TBL] [Abstract][Full Text] [Related]
7. Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese.
Chan KH; Lee R; Lee JC; Tse AC; Pang SY; Lau GK; Teo KC; Ho PW
J Neuroimmunol; 2013 Sep; 262(1-2):100-5. PubMed ID: 23838529
[TBL] [Abstract][Full Text] [Related]
8. Innate and adaptive autoimmunity directed to the central nervous system.
Bhat R; Steinman L
Neuron; 2009 Oct; 64(1):123-32. PubMed ID: 19840554
[TBL] [Abstract][Full Text] [Related]
9. Autoreactive T and B cells in nervous system diseases.
Sun JB
Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
[TBL] [Abstract][Full Text] [Related]
10. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders.
Hinson SR; Lennon VA; Pittock SJ
Handb Clin Neurol; 2016; 133():377-403. PubMed ID: 27112688
[TBL] [Abstract][Full Text] [Related]
12. Immunopathology: autoimmune glial diseases and differentiation from multiple sclerosis.
Popescu BF; Lucchinetti CF
Handb Clin Neurol; 2016; 133():95-106. PubMed ID: 27112673
[TBL] [Abstract][Full Text] [Related]
13. Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis.
Dittel BN
Arch Immunol Ther Exp (Warsz); 2000; 48(5):381-8. PubMed ID: 11140465
[TBL] [Abstract][Full Text] [Related]
14. B cells as therapeutic targets in autoimmune neurological disorders.
Dalakas MC
Nat Clin Pract Neurol; 2008 Oct; 4(10):557-67. PubMed ID: 18813230
[TBL] [Abstract][Full Text] [Related]
15. Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases.
Riedhammer C; Weissert R
Front Immunol; 2015; 6():322. PubMed ID: 26136751
[TBL] [Abstract][Full Text] [Related]
16. Editorial: Induction of Central Nervous System Disease by the Adaptive Immune Response.
Weissert R; Brilot F
Front Immunol; 2017; 8():1218. PubMed ID: 29038655
[No Abstract] [Full Text] [Related]
17. B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets.
Forsthuber TG; Cimbora DM; Ratchford JN; Katz E; Stüve O
Ther Adv Neurol Disord; 2018; 11():1756286418761697. PubMed ID: 29593838
[TBL] [Abstract][Full Text] [Related]
18. Recent insights into the pathology of multiple sclerosis and neuromyelitis optica.
Wegner C
Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S38-41. PubMed ID: 24321153
[TBL] [Abstract][Full Text] [Related]
19. [Neuromyelitis optica].
Kvistad SA; Wergeland S; Torkildsen Ø; Myhr KM; Vedeler CA
Tidsskr Nor Laegeforen; 2013 Oct; 133(19):2057-61. PubMed ID: 24129537
[TBL] [Abstract][Full Text] [Related]
20. Anti-NMDAR encephalitis followed by seropositive neuromyelitis optica spectrum disorder: A case report and literature review.
Ran Y; Wang L; Zhang F; Ao R; Dong Z; Yu S
Clin Neurol Neurosurg; 2017 Apr; 155():75-82. PubMed ID: 28282627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
